Literature DB >> 27117532

Precision medicine and oncology: an overview of the opportunities presented by next-generation sequencing and big data and the challenges posed to conventional drug development and regulatory approval pathways.

M Doherty1, T Metcalfe2, E Guardino3, E Peters3, L Ramage2.   

Abstract

Mesh：

Year:  2016        PMID： 27117532     DOI： 10.1093/annonc/mdw165

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

Review 1.  Machine learning approaches to drug response prediction: challenges and recent progress.

Authors:  George Adam; Ladislav Rampášek; Zhaleh Safikhani; Petr Smirnov; Benjamin Haibe-Kains; Anna Goldenberg
Journal:  NPJ Precis Oncol       Date:  2020-06-15

Review 2.  Translational Bioinformatics for Cholangiocarcinoma: Opportunities and Challenges.

Authors:  Fuliang Qian; Junping Guo; Zhi Jiang; Bairong Shen
Journal:  Int J Biol Sci       Date:  2018-05-22       Impact factor: 6.580

Review 3.  Machine learning approaches to drug response prediction: challenges and recent progress.

Authors:  George Adam; Ladislav Rampášek; Zhaleh Safikhani; Petr Smirnov; Benjamin Haibe-Kains; Anna Goldenberg
Journal:  NPJ Precis Oncol       Date:  2020-06-15

Review 4.  Precise hepatectomy in the intelligent digital era.

Authors:  Hao Chen; Yuchen He; Weidong Jia
Journal:  Int J Biol Sci       Date:  2020-01-01       Impact factor: 6.580
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.